Nuclear scintigraphic assessment of intestinal dysfunction after combined treatment with 9-amino-20(S)-camptothecin (9-AC) and irradiation

International Journal of Radiation Oncology Biology Physics

Volumn 47, Issue 4, 2000, Pages 1043-1049

  Kirichenko, Alexander V ^a   Mason, Kathryn ^b   Straume, Martin ^a   Teates, Charles D ^a   Rich, Tyvin A ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

99mTc pertechnetate; Camptothecins; Dynamic scintigraphy; Intestinal absorption; Irradiation

Indexed keywords

CAMPTOTHECIN; PERTECHNETIC ACID TC 99M;

ACTIVE TRANSPORT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; INTESTINE INJURY; JEJUNUM MUCOSA; MORPHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION INJURY; RADIOSENSITIZATION; SCINTIGRAPHY; SMALL INTESTINE ABSORPTION;

ANIMALS; ANTINEOPLASTIC AGENTS; CAMPTOTHECIN; FEMALE; INTESTINAL ABSORPTION; JEJUNUM; MICE; MICE, INBRED C3H; RADIATION DOSAGE; RADIOBIOLOGY; RADIOPHARMACEUTICALS; SODIUM PERTECHNETATE TC 99M; WHOLE-BODY IRRADIATION;

EID: 0034237202     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00507-1     Document Type: Article

References (32)

1. Drengler R., Buris H., Dietz A., et al. A phase-I trial to evaluate orally administered irinotecan-HCL (CPT-11) given daily(5 every 3 weeks in patients with refractory malignancies. Proc ASCO. 15:1996;489.
2. Shimada Y., Yoshino M., Wakui A., et al. Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer. J Clin Oncol. 11:1993;909-913.
3. Rothenberg M.L. Topoisomerase I inhibitors Review and update . Ann Oncol. 8:1997;837-855.
4. Boothmann D.A., Fukunada N., Wang M. Down-regulation of topoisomerase 1 in mammalian cells following ionizing radiation. Cancer Res. 54:1994;4618-4626.
5. Lamond J., Wang M., Kinsella T., et al. Radiation lethality enhancement with 9-amino camptothecin Comparison to other topoisomerase 1 inhibitors . Int J Radiat Oncol Biol Phys. 36:(2):1996;369-3376.
6. Nelson W.G., Kastan M.B. DNA strand breaks Of the DNA template alterations that trigger p53-dependent DNA damage response pathways . Mol Cell Biol. 14:1994;1815-1823.
7. Falk S.J., Smith P.J. DNA damaging and cell cycle effects of the topoisomerase 1 poison camptothecin in irradiated human cells. Int J Radiat Biol. 61:(6):1992;749-757.
8. Del Bino G., Bruno S., Yi P.N., et al. Apoptotic cell death triggered by camptothecin or teniposide. The cell cycle specificity and effects of ionizing radiation. Cell Prolif. 25:1992;537-548.
9. Araki E., Ishicawa M., Ligo M., et al. Relationship between development of diarrhea and the concentration of SN-38, an active methabolite of CPT-11, in the intestine and blood plasma of athymic mice following intraperitoneal administration of CPT-11. Jpn J Cancer Res. 87:1993;697-702.
10. Takasuna K., Hagivara T., Hirohashi M., et al. Involvement of β-glucuronidase in intestinal microflora in the intestinal toxicity of antitumor camptothecin derivative irinotecn hydrochloride (CPT-11) in rats. Cancer Res. 56:1996;3752-3757.
11. Kirichenko A.V., Rich T.A., Newman R.A., et al. Potentiation of murine MCA-4 carcinoma radioresponse by 9-amino20 (S)-camptothecin. Cancer Res. 57:1997;1929-1933.
12. Withers H.R., Elkind M. Microcolony survival assay for cells of mouse intestinal mucosa exposed to radiation. Int J Radiat Biol. 17:1970;261-268.
13. Kirichenko A.V., Rich T.A. Radiation enhancement by 9-aminocamptothecin The effect of fractionation and timing of administration . Int J Radiat Oncol Biol Phys. 3:1999;659-664.
14. Straume M., Frasier-Cadoret S.G., Johnson M.L. Least squares analysis of fluorescence data. Lakowicz J.R. Topics in fluorescence spectroscopy, principles. Vol. 2:1991;117-240 Plenum, New York.
15. Johnson M.L., Frasier S.G. Nonlinear least squares analysis. Methods Enzymol. 117:1985;301-342.
16. Kirichenko A.V., Mason K., Straume M., et al. Nuclear scintigraphic assessment of radiation-induced intestinal dysfunction. Radiat Res. 153:2000;164-172.
17. Thompson A.B.R., Cheeseman C.I., Walker K. Effect of abdominal irradiation on the kinetic parameters of intestinal uptake of glucose, galactose, leucine, and gly-leucine in the rat. J Lab Clin Med. 102:1983;813-827.
18. Beciollini A., Gerber G.B., Deroo J. In vivo absorption of carbohydrates in rats with gastro-intestinal radiation syndrome. Acta Radiol Ther Phys Biol. 16:1977;87-96.
19. Overgaard J., Matsui M. Effect of radiation on glucose absorption in the mouse jejunum in vivo. Radiother Oncol. 18:1990;71-77.
20. Gunter-Smith P.J. Ionizing radiation affects active electrolyte transport by rabbit ileum Correlation of alanine and theophylline response with morphology . Radiat Res. 117:1989;419-432.
21. Helman J., Turner R.J., Fox P.C., et al. 99mTc-Pertechnetate uptake in parotid acinar cells by the Na+/K+/Cl- co-transport system. J Clin Invest. 79:1987;1310-1313.
22. Barret K.E., Dharmsathaphorn K. Secretion and absorption. Yamada T. Textbook of gastroenterology. 1991;265-294 JB Lippincott, Philadelphia.
23. Bellen J.C., Chatterton B.E., Penglis S., et al. Gallium-67 complexes as radioactive markers to assess gastric and colonic transit. J Nucl Med. 36:1995;513-517.
24. Tsan M.F., Scheffel U. Gallium-67 accumulation in inflammatory lesions. J Nucl Med. 20:1979;173.
25. Anghileri L.R. Role of tumor cell membrane in hyperthermia. Anghileri L.R., Robert J. Hyperthermia in cancer treatment. Vol. 1:1986;1-36 CRC Press, Boca Raton.
26. Porvaznik M. Tight junction disruption and recovery after sublethal γ-irradiation. Radiat Res. 78:1979;233-250.
27. Kwock L., Lin P.-S., Ciborowsky L. Differences in the effect of ionizing radiation on Na+-dependent amini acid transport in human T (Molt-4) and human B (RPMI 1788) lymphoid cells. Radiat Res. 80:1979;512-522.
28. Potten CS, Hendry JH. Radiation and gut. Elsevier, New York: Elsevier Science; 1995.
29. Ruifrok A.C., Weil M.M., Thames H.D., et al. Diurnal variations in the expression of radiation-induced apoptosis. Radiat Res. 149:1998;360-365.
30. McCarthy N.J.M., Whyte K.B., Gilbert C.S., et al. Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced oncogenes, DNA damage, or the Bcl-2 homologue Bak. J Cell Biol. 136:1997;215-227.
31. Brunet C.L., Gunby R.H., Benson R.S.P., et al. Commitment to cell death measured by loss of clonogenicity is separable from the appearance of apoptotic markers. Cell Death Differ. 5:1998;107-118.
32. Ikuno N., Soda H., Watanabe M., et al. Irinothecan (CPT-11) and characteristic changes in the mouse ileum and cecum. J Natl Cancer Inst. 24:1995;1876-1883.